8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|Metastatic Breast Cancer
Interventions: DRUG: Paclitaxel, Bevacizumab, liposomal doxorubicin, Capecitabine|DRUG: Paclitaxel, Bevacizumab, liposomal doxorubicin, Capecitabine
Sponsor: Borstkanker Onderzoek Groep
Collaborators: Roche Pharma AG|Teva Pharma